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Effects of renal arterial angiotensin I infusion on glomerular dynamics
in sodium replete dogs. During intrarenal infusion of angiotensin I (Al),
conversion to angiotensin II (All) within the kidney has been shown
to occur early enough to decrease glomerular filtration rate (GFR). To
evaluate further the mechanism by which Al decreases GFR, micro-
puncture studies were conducted in sodium replete dogs. Feedback-
mediated alterations in glomerular function were minimized by reduc-
ing renal arterial pressure to 90 mm Hg. During infusion of Al (0.82
0.01 g min), renal blood flow (3.91 0.25 ml min g1) and GFR
(0.63 0.04 ml min g) decreased by 36.7 6.1% and 18.9
6.1%, respectively. Similarly, single nephron GFR decreased from 66.4
3.8 to 40.0 3.2 nl mm' and estimated glomerular plasma flow
(280 49 nI min) decreased by 55 6%. Stop-flow pressure (40.5
3.6 mm Hg) did not change significantly, while proximal tubular
(21.8 1.4 mm Hg) and peritubular capillary pressures (13.2 1.8
mm Hg) decreased by 25.5 2.8% and 49.4% 5.1%, respectively.
Glomerular capillary and effective filtration pressures were not altered
significantly. There were increases in both preglomerular (168%) and
efferent (203%) arteriolar resistances, along with a decrease in the
glomerular filtration coefficient (K1) from 4.6 0.6 to 2.5 0.5 nl mm
Hg mm -. These data indicate that augmented intrarenal conver-
sion of circulating Al reduces GFR as a consequence of decreases in
K1 as well as in glomerular plasma flow, the latter being due to con-
comitant increases in preglomerular and efferent arteriolar resistances.
Effets d'une perfusion artérielle rénale d'angiotensine I sur Ia dyna.
mique glomerulaire ches des chiens en réplétion sodée. Pendant une
perfusion intrarénale d'angiotensine I (Al), il a été montré que Ia con-
version en angiotensine II (All) dans le rein survient suffisamment tot
pour diminuer le debit de filtration glomérulaire (GFR). Afin de
préciser plus le mécanisme par lequel Al diminue GFR, des etudes de
microponction ont été entreprises chez des chiens en réplétion sodée.
Les alterations de Ia fonction glomerulaire par mécanisme de
rétrocontrôle ont été minimisées en réduisant Ia pression artérielle
rénale a 90mm Hg. Pendant la perfusion d'AI (0,82 0,01 pg min'),
le debit sanguin renal (3,91 0,25 ml min' g), et GFR(0,63 0,04
ml mm' g') ont diminué de 36,7 6,1% et 18,9 6,1%, respec-
tivement. De mCme, GFR néphronique individuel a diminué de 66,4
3,8 a 40,0 3,2 nI min et le debit plasmatique glomérulaire estimé
(280 49 nI min) a diminué de 55 6%. La pression d'occlusion
(40,5 3,6 mm Hg) ne s'est pas modifiée significativement alors que
les pressions tubulaires proximales (21,8 1,4 mm Hg) et capillaires
péritubulaires (13,2 1,8 mm Hg) ont baissé de 25,5 2,8% et 49,4
5,1%, respectivement. La pression capillaire glomerulaire et Ia pres-
sion de filtration efficace n'ont pas été significativement modifiées. Ii y
a eu une élévation des resistances artériolaires prdglomerulaires (168%)
et efférentes (203%), en méme temps qu'une diminution du coefficient
de filtration glomerulaire (Kf) de 4,6 0,6 a 2,5 0,5 nI mm Hg.
Ces données indiquent que l'augmentation de Ia conversion intrarénale
de l'AI circulante diminue GFR par des baisses de Kf et du debit
plasmatique glomerulaire, cette dernière étant due a des élévations
concomitantes des resistances artériolaires preglomerulaires et
efférentes.
The physiological role of circulating angiotensin II (All) in
the control of renal hemodynamics and, specifically, glomer-
ular filtration rate (GFR) has been studied extensively [1—5]. It
is now recognized that the kidney has endothelial cell-bound
angiotensin converting enzyme in the preglomerular and
glomerular vessels [6, 71 which can convert systemically de-
livered angiotensin I (Al) to All; however, such effects on re-
nal function have generally been ignored. The observations
that Al concentrations in arterial blood are several times higher
than arterial All concentrations [8—101, together with the sub-
stantial capacity of the kidney for conversion of systemically
delivered Al [10], suggest that at least part of the effects of the
renin-angiotensin system on renal hemodynamics could be me-
diated by arterially delivered angiotensin I.
In experiments where Al and All infusions were studied
concurrently, it was recognized that even equiconstrictor doses
might produce slightly different, although subtle, effects on re-
nal hemodynamics [11—14]. In a recent study in which Al and
All were infused to elicit equivalent reductions in renal blood
flow (RB F), we observed that GFR was more consistently de-
creased during the Al infusions [14]. These data indicate that
the intrarenal conversion of intra-arterially infused Al occurs
at vascular sites early enough to allow the locally formed All
to decrease GFR; however, we did not determine the mecha-
nism responsible for the decreased GFR. Therefore, micro-
puncture experiments were conducted to evaluate the sites of
action of All, generated by intrarenal conversion of arterially
administered Al. Experiments were performed on sodium re-
plete dogs to minimize the influence of endogenous angioten-
sin on renal function. Measurements of single nephron GFR
(SNGFR), along with micropressure data, allowed calculation
of the glomerular filtration coefficient (Kf) as well as preglomer-
ular and efferent arteriolar resistances. The results indicate that
All generated intrarenally from circulating Al reduces SN-
GFR through effects involving decreases in Kf as well as in
glomerular plasma flow.
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Methods
Eleven mongrel dogs of both sexes ranging in weight from
15 to 21 kg were studied. For 3 days prior to the experiment,
sodium chloride (1.5 glkg body weight) was added to the daily
standard dog food (Purina Dog Chow, Ralston Purina, Rich-
mond, Virginia). The animals were last fed about 16 hr before
the experiment. Water was available ad libitum.
The dogs were anesthetized with sodium pentobarbital (25 to
30 mg kg I), supplemented as needed to maintain an appro-
priate level of anesthesia. A tracheostomy was performed and
catheters were inserted in jugular and femoral veins for sys-
temic administration of drugs and additional anesthetic as
needed. A femoral artery was catheterized for recording arte-
rial BP using a Statham pressure transducer and polygraph re-
corder (Model 7D, Grass Instrument Co., Quincy, Massachu-
setts). The left kidney was exposed through a flank incision and
the fascia surrounding the kidney was removed. The renal ar-
tery and vein were dissected free and an electromagnetic flow
probe (Carolina Medical Electronics, King, North Carolina)
was placed around the renal artery close to the aorta. A 22-
gauge curved needle was inserted in the artery for measure-
ment of renal arterial pressure (RAP) and for intrarenal infu-
sion of angiotensin 1. This catheter was kept patent by continu-
ous infusion of a heparinized saline solution at a rate of 0.15
ml mm . To adjust RAP, a plastic clamp was placed around
the renal artery between the needle and the flow probe. The
ureter was catheterized for urine collections. As previously de-
scribed, the kidney was placed on a holder (Lucite®), and ap-
proximately 2 cm2 of renal capsule were removed. The kidney
was wrapped with cotton and the exposed decapsulated sur-
face bathed with warm (37°C) saline solution dripped through
a quartz rod also used for illumination. To minimize tubulo-
glomerular feedback-mediated alterations in glomerular func-
tion that might occur in response to tubule blockade during
complete proximal tubular fluid collections or proximal stop-
flow pressure measurements, RAP was reduced to 85 to 95 mm
Hg and maintained at this level for the duration of the experi-
ment [15]. Previous studies in our laboratory [15—171 have in-
dicated that estimates of single nephron glomerular filtration
rate (SNGFR) and glomerular pressure obtained in this setting
are more representative of those existing in unblocked
nephrons.
A 5% solution of inulin in 0.9% sodium chloride was admin-
istered as a priming dose (3.2 ml kg') followed by a sustain-
ing infusion at 0.08 ml kg min'. Following a 45-mm equil-
ibration period, urine samples were collected for two 30- to 40-
mm periods for control clearance measurements. Arterial
blood samples were collected at the mid-point of each of these
periods. Micropressure measurements and tubular fluid collec-
tions were performed during these clearance periods. Four to
six measurements of proximal tubular pressure (PTP), stop-
flow pressure (SFP), and peritubular capillary pressure (PCP)
were taken with a micropressure servo-null system (Instrumen-
tation for Physiology and Medicine, San Diego, California).
Stop-flow pressure was measured in tubules blocked with wax
[14]. Also, timed total collections of proximal tubular fluid
were obtained from three to six nephrons to assess single neph-
ron GFR (SNGFR). Following the control measurements, an-
giotensin I (2.5 g ml') in a 0.9% heparinized sodium chlo-
ride solution was infused into the renal artery in six dogs at a
dose sufficient to reduce RBF by about 30%. In five dogs used
for control studies, a heparinized sodium chloride solution
without Al was infused to assess changes due to the time
elapsed. Ten minutes after initiation of the infusion, clearance
and micropuncture measurements were repeated in the man-
ner described above.
An anthrone technique was used to determine inulin concen-
tration in plasma and urine samples. Glomerular filtration rate
(GFR) was calculated by the standard clearance formula. Hem-
atocrit measurements were performed on all femoral arterial
blood samples. Whole kidney filtration fraction (FF) was de-
termined from GFR and renal plasma flow, derived from the
measured values for RBF and arterial hematocrit. Plasma col-
bid osmotic pressure was measured directly with a membrane
osmometer (Model 4100, Wescor, Logan, Utah). The quanti-
tative relationship between plasma protein concentration and
colloid osmotic pressure for the dog has been described in de-
tail [18]. To determine the status of the renin-angiotensin sys-
tem, blood samples were collected into chilled tubes contain-
ing EDTA for determination of plasma renin activity (PRA) by
radioimmunoassay [19]. To determine tubular fluid volumes,
samples were transferred to a calibrated constant bore capil-
lary and measured with a slide comparator. Inulin concentra-
tion in tubular fluid samples was determined using a microfluo-
rometric method [20], and SNGFR was calculated from the
product of tubular flow and the tubular fluid-to-plasma inulin
concentration ratio. Glomerular capillary pressure (GCP) was
estimated from the sum of SFP and plasma colloid osmotic
pressure (ITa). Glomerular blood flow (GBF) and gbomerular
plasma flow (GPF) were computed from filtration fraction, sin-
gle nephron glomerular filtration rate, and hematocrit:
(1)
GPF SNGFR (2)FF
Whole kidney FF values were used for these calculations since
we were not able to obtain efferent arteriolar blood samples
routinely during the angiotensin infusion phases of the study.
Single nephron resistances of preglomerular (afferent, AR) and
efferent (ER) arterioles were calculated by the expressions:
AR = RAP-GCP (3)GBF
and
ER = GCP
— PCP (4)GBF - SNGFR
Resistances are expressed in units of mm Hg mm nl .
The gbomerular filtration coefficient (K1) was calculated using
an equation previously described in detail [16]:
(5)
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RAP
mmHg
RBF
m1min'g
GFR
mlmin1g' FF
Control 91 3.91 0.63 0.28
Al infusion 93 2.47a 0.50" 0.36b
where P is the transglomerular hydrostatic pressure, and R is
a constant relating lTa and FF to the efferent arteriolar colloid
osmotic pressure. This approach is particularly useful in dog
studies because the value of R (43.3) is affected only slightly
by variations in albumin-to-globulin ratios, which are substan-
tial in this species. Finally, the mean effective filtration pres-
sure (EFP) was calculated from the quotient of SNGFR and Kf.
Statistical evaluation of differences between the control
measurements and the second set of measurements was con-
ducted using repeated measures of analysis of variance. Sta-
tistical differences were accepted when P values were 0.05 or
less.
Results
The efficacy of the high sodium diet in reducing the activity
of the renin-angiotensin system was evidenced by the PRA lev-
els which averaged 1.7 0.7 ng Al m1' hrt, a value lower
than those reported for dogs maintained on a normal sodium
diet [10, 17]. At the spontaneous RAP of 114 6 mm Hg, RBF
was 3.91 0.24 ml min1 g1. When RAP was reduced to 91
3 mm Hg, RBF was not altered significantly (RBF: —1.3
2.9%). Data on whole kidney function before and during the
intrarenal infusion of Al are summarized in Table 1. During the
intra-arterial infusion of Al (0.82 0.01 tg mint), systemic
arterial pressure increased slightly but not significantly
(BP:6.0 3.9%). In the individual dog, RAP was maintained
at control levels (RAP:2.7 0.7%) by adjustment of the re-
nal arterial clamp. In response to the Al infusion, RBF de-
creased by 36.7 6.1% and GFR decreased significantly by
18.9 6.1%; consequently, FF increased by 31.0 8.3%.
This increase in the filtration fraction is similar to that previ-
ously observed [14]. During the time-control experiments there
were small numerical decreases in GFR and increases in FF;
however, these changes were not statistically significant. The
slow progressive decrease in RBF (16.2 1.9%), often seen
during the course of micropuncture experiments, was much
less than that observed during the infusion of Al (P < 0.02).
During the control period, SNGFR was 66.4 3.8 nl min'
and decreased consistently to an average of 40.0 3.2 nI
min1 during the infusion of Al (Fig. 1). As an index of pos-
sible changes in intrarenal GFR distribution associated with Al
infusion, the ratio of whole kidney GFR (ml min' g')-to-
SNGFR (nI mint) was calculated. The small increase in this
ratio from 1.0 0.1 (xl02) to 1.3 0.2 (xl02) was not
statistically significant. The micropressure responses to the in-
fusion of Al are shown in Table 2. Both PTP and PCP de-
I I
Control Al
Fig. 1. Effects of renal arterial infusion of angiotensin I on single neph-
ron glomerular filtration rate (SNGFR) at reduced renal arterial pres-
sure (N = 6; ***, P < 0.001).
Table 2. Effects of renal arterial infusion of angiotensin I on
micropressures in surface nephrons (N = 5)
PTP PCP SFP lTa GCP LP
mm Hg
Control
AT infusion
21.8
16.la
13.2
6.5"
40.5
40.5
14.5
13.7
55.0
54.2
33.2
38.1
Abbreviations: PTP, proximal tubular pressure; PCP, peritubular
capillary pressure; SFP, stop flow pressure; ITa, arterial plasma colloid
osmotic pressure; GCP, glomerular capillary pressure; P, transglo-
merular hydrostatic pressure difference.
a P < 0.05.
"P < 0.001.
creased significantly during Al infusion (PTP: —25.5 2.8%;
zPCP: —49.4 5.1%) indicating a clear response by the super-
ficial nephrons. Stop-flow pressure, however, did not change
significantly (SFP:l.2 5.8%) during the infusion of A!.
Consequently, calculated GCP was not altered (GCP: —0.9
3.8%). During the control period, effective filtration pressure
was 15.1 2.6 mm Hg and this was slightly, but not signifi-
cantly, increased during Al infusion to a level averaging 18.5
3.7 mm Hg. All of these pressure responses to Al infusion
were similar to those observed at spontaneous renal arterial
pressures in dogs maintained on a high sodium diet [14]. In this
previous study, arterial pressure averaged 119 4 and 123
5 mm Hg during control and Al infusion periods; PTP was
found to decrease from 21 0.7 to 17 0.6 mm Hg (N = 11,
P < 0.001) and PCP was reduced from 13.9 0.8 to 9.2 0.7
mm Hg (P < 0.001). Control SFP values were substantially
higher (53.5 1.4 mm Hg) than in the present study; how-
ever, they were unaffected by Al at spontaneous RAP, aver-
aging 52.6 2.4 mm Hg during Al infusion (N = 5). In the
Table 1. Effects of renal arterial infusion of angiotensin I on whole
kidney function at reduced renal arterial pressure (N = 6)
Abbreviations: RAP, renal arterial pressure; RBF, renal blood flow;
GFR, glomerular filtration rate; FF, ifitration fraction.
a P < 0.001.
b P < 0.05.
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I I
Control Al
Fig. 2. Effects of renal arterial infusion of angiotensin I on glomerular
filtration coefficient (Kr) and preglomerular (AR) and efferent (ER) ar-
teriolar resistances at reduced renal arterial pressure (N = 5; ', P <
0.01; P < 0.001).
present study, no significant changes in superficial nephron
function were observed during the time control experiments,
with the exception of a small decrease in PCP of 2.6 0.4 mm
Hg.
The computed glomerular plasma flow was 280 49 nl
min and decreased significantly to 119 17 nl min' during
the Al infusion. Calculated preglomerular and efferent arteri-
olar resistances increased from 0.08 0.01 and 0.12 0.02 to
0.22 0.04 and 0.35 0.06 mm Hg mm nLt, respectively
(Fig. 2). The glomerular filtration coefficient (Kf) computed
from these data decreased substantially from 4,58 0.60 to
2.54 0.48 nI mm Hg' min'.
Discussion
The present study represents an extension of previous ob-
servations on the hemodynamic responses to intrarenal infu-
sion of angiotensin I. Earlier experiments demonstrated that
the hemodynamic effects of Al were essentially abolished by
prior administration of converting enzyme inhibitors [14, 211.
Furthermore, since renal blood flow of the noninfused contra-
lateral kidney was reduced to a much lesser extent [141, it was
concluded that a substantial component of the reduction in
RBF occurring during renal arterial Al infusion was due spe-
cifically to the local conversion of Al to All rather than to the
effects of circulating All formed within the pulmonary vascu-
lature. These observations are in concert with the concept that
one functional role of the renin-angiotensin system involves
converting enzyme-dependent formation of All within the kid-
ney and that this process may occur independent of plasma
renin activity and circulating All levels [7, 221.
The present results suggest that, in addition to increasing
both afferent and efferent arteriolar resistance, locally con-
verted angiotensin reduces the glomerular filtration coefficient.
Under these imposed conditions of suppressed endogenous an-
giotensin activity and reduced renal arterial pressure, the in-
fluence of Al was striking. Changes of this magnitude may not
occur under normal physiological conditions [171. In addition,
the magnitude of the changes observed may have been influ-
enced by limitations inherent in the methods employed in this
study. The validity of estimates of single nephron FF based on
whole kidney parameters depends on the equivalency of
angiotensin's influence on the entire nephron population. In an
earlier study [17] we found that inhibition of a highly active
renin-angiotensin system by administration of captopril to so-
dium-depleted dogs had identical effects on whole kidney and
single nephron FF. SNGFR appeared to decrease to a greater
extent that did GFR in the present study; however, our obser-
vation that the ratio of whole kidney-to-single nephron GFR
was not significantly altered by Al infusion suggests the ab-
sence of large regional differences in the effects of Al on FF
[13]. These considerations indicate that the error introduced by
utilizing whole kidney FF as an estimate of SNFF in the cal-
culations regarding single nephron hemodynamics is likely
small in comparison to the large changes observed in response
to Al.
Since study of glomerular dynamics in the dog precludes di-
rect measurement of GCP, changes in this parameter were
assessed based on SFP measurements. Although SFP overesti-
mates GCP at normal pressures because of an altered operat-
ing level of the tubuloglomerular feedback system, earlier
observations indicate that this error is minimized at reduced
renal arterial pressure [15, 17, 18]. This procedure is also pre-
sumed to reduce the error inherent in determination of SN-
GFR based on total proximal tubular fluid collections. In any
case, the microvascular and tubular pressure responses to Al
were quite similar when studied at spontaneous and reduced
pressures. Thus, although methodological limitations contrib-
ute some uncertainty regarding the absolute values of Kf and
arteriolar resistances, these data reflect rather consistent direc-
tional responses in Kf, SNGFR, and glomerular plasma flow as
a result of enhanced local conversion of circulating Alto All.
Although there are multiple potential Al conversion sites
within the kidney, both the previous studies and the current set
of experiments indicate that at least part of the conversion
process occurs sufficiently early within the renal vasculature to
elicit reductions in GFR. To achieve these effects, at least one
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locus of conversion must be anatomically situated allowing the
delivery of All to contractile structures which can be function-
ally identified as preglomerular and/or glomerular. This con-
clusion is compatible with the immunohistochemical studies
which have localized angiotensin converting enzyme activity at
the level of the arcuate, interlobular, and afferent arterioles and
the stem capillaries of the glomerular tuft, as well as the ef-
ferent arteriole [7].
As noted, the data indicate that Al infusion elicited concomi-
tant effects on both preglomerular and efferent arteriolar resist-
ances. The observed increase in efferent arteriolar resistance
agrees with a large number of experiments using both angio-
tensin infusions and antagonists of the renin-angiotensin sys-
tem [14, 17, 23—27]. There is less agreement with regard to the
effects observed on preglomerular resistance. In some previ-
ous studies using systemic angiotensin II infusions, increases
in preglomerular resistance have been attributed, at least in
part, to the associated increases in systemic arterial pressure
[25, 26]. An advantage offered by the present experiments con-
ducted in dogs was the ease of access to direct renal arterial
infusion, thus minimizing systemic pressor effects. In addition,
the utilization of an adjustable renal arterial clamp allowed us
to make all measurements at the same renal perfusion pres-
sure. Accordingly, the present data suggest that All formed
from systemically delivered Al can increase preglomerular
resistance independent of adjustments occurring as a conse-
quence of the autoregulatory mechanism.
The exact anatomical site where angiotensin increases pre-
glomerular resistance remains in question. The renal arteriolar
response to topical application of All has been evaluated using
isolated vessels in vitro and transplanted renal tissue in the
hamster cheek pouch. In these studies, afferent arteriolar di-
ameter was either unaffected or reacted to a modest degree in
response to All [28, 29]. These results do not mitigate against
the possibilities that the functional preglomerular resistance el-
ements may be anatomically located at discrete sites immedi-
ately proximal to the glomerular capillaries or that they may ac-
tually be part of the contractile system of the glomerular
structures.
In agreement with investigations in the rat using systemic ad-
ministration of All, the present experiments demonstrate that
Al infusions lead to substantial reductions in superficial neph-
ron GFR which are due, in large part, to consistent decreases
in K1 [24, 271. Such changes in K1 could be of even greater
physiological significance in the dog than in the rat, since the
dog is not generally thought to be in filtration equilibrium [5,
15, 161. The exact mechanism by which angiotensin can re-
duce Kf remains unclear; however, a number of studies have
noted the presence of All receptors predominantly on the
mesangial cells of the glomeruli, as well as on the basement
membrane [30—32]. Since converting enzyme is also present, it
is possible that All is formed in the immediate vicinity of the
receptors and that the locally effective All concentration thus
produced is greater than the free plasma concentration of All.
Since the elements within the glomerular corpuscle presum-
ably have little direct contact with the interstitial fluid of the
peritubular spaces, it is unlikely that the tissue All levels or
All formed beyond the glomerulus could directly influence the
K1 prior to recirculation. Consequently, the direct glomerular
and perhaps functional preglomerular responses seen during
the Al infusion were most likely mediated by All delivered via
the converting enzyme sites to the contractile elements. Ob-
servations from both in vitro and micropuncture studies have
suggested that mesangial cell contraction may be involved in
the glomerular response to angiotensin [33—361. If, indeed, All-
mediated mesangial cell contraction can be responsible for the
observed reductions in Kf the precise mechanism by which this
occurs remains to be determined.
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